Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      Volition Expands Contract with Fujifilm to Include the Nu.Q® Vet Test for Cats
      Health

      Volition Expands Contract with Fujifilm to Include the Nu.Q® Vet Test for Cats

      November 16, 2026
      Jamieson Wellness Inc. Reports Third Quarter 2026 Results
      Health

      Jamieson Wellness Inc. Reports Third Quarter 2026 Results

      November 16, 2026
      Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update
      Health

      Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update

      November 16, 2026
      Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
      Health

      Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)

      November 16, 2026
      Apotex launches Axitinib Tablets in the U.S., the first generic version of INLYTA®
      Health

      Apotex launches Axitinib Tablets in the U.S., the first generic version of INLYTA®

      November 16, 2026
      INVESQUE ANNOUNCES SHAREHOLDER APPROVAL OF GO-PRIVATE TRANSACTION
      Health

      INVESQUE ANNOUNCES SHAREHOLDER APPROVAL OF GO-PRIVATE TRANSACTION

      November 16, 2026
      Cytokinetics Announces Prescribing Information for MYQORZO® (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM
      Health

      Cytokinetics Announces Prescribing Information for MYQORZO® (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM

      November 16, 2026
      Aclaris Therapeutics Announces Top Line Phase 2 Results for its Anti-TSLP Monoclonal Antibody Bosakitug (ATI-045) in Atopic Dermatitis (AD)
      Health

      Aclaris Therapeutics Announces Top Line Phase 2 Results for its Anti-TSLP Monoclonal Antibody Bosakitug (ATI-045) in Atopic Dermatitis (AD)

      November 16, 2026
      Aclaris Therapeutics Initiates Phase 2b Trial of Modzatinib (ATI-2138) in Lichen Planus (LP)
      Health

      Aclaris Therapeutics Initiates Phase 2b Trial of Modzatinib (ATI-2138) in Lichen Planus (LP)

      November 16, 2026
      Philips to nominate Dick Boer, Laurence Debroux and Todd Brinton to its Supervisory Board at the 2027 Annual General Meeting of Shareholders (AGM)
      Health

      Philips to nominate Dick Boer, Laurence Debroux and Todd Brinton to its Supervisory Board at the 2027 Annual General Meeting of Shareholders (AGM)

      November 16, 2026
      1 2 3 … 275 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026